- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07665242
Chatbot Intervention Effects on Social and Monetary Incentive Processing in Anhedonia
Effects of a Chatbot-Based Intervention on Behavioral Responsiveness and Neural Anticipation of Social and Monetary Incentives in Individuals With Anhedonia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Anhedonia represents a core characteristic of depression and is characterized by reduced experience of pleasure. It is closely related to decreased motivation, altered reward processing, changes in affective responsiveness, and alterations in intrinsic brain network function. Anhedonia is not specifically targeted by currently available pharmacological interventions. Initial evidence indicates that an increased willingness to change and implementation of change in daily life can alleviate anhedonia.
The present study aims to examine whether a Motivational Interviewing-based AI chatbot can lead to changes in social incentive processing in college students with elevated anhedonia and depressive symptoms. Social incentive processing is included because social approval, social feedback, and interpersonal reward are important sources of motivation in daily life and may be altered in individuals with elevated anhedonia. The Social Incentive Delay Task allows the study to examine behavioral and neural responses during the anticipation and receipt of social incentives. To this end, eligible participants with a total score of 23.5 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory will undergo a randomized, between-subjects, active-control intervention study. Participants will be assigned to either a Motivational Interviewing-based chatbot group or an active control chatbot group for 1 week. Pre- and post-intervention assessments will include self-report questionnaires and the Social Incentive Delay Task during functional magnetic resonance imaging to examine psychological, behavioral, and neural effects of the intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Benjamin Becker, Dr
- Phone Number: (852) 3917-5097
- Email: bbecker@hku.hk
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China
- Recruiting
- University of Electronic Science and Technology of China
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-40 years
- Right-handed
- Normal or corrected normal visual acuity
- Participants must show elevated anhedonia and depressive symptoms at screening, defined as a total score of 23.5 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory
Exclusion Criteria:
- History of major central nervous system disorders, such as epilepsy, traumatic brain injury, stroke, or brain tumors.
- History of severe mental illness, including schizophrenia spectrum disorders, bipolar disorder, or other psychotic disorders.
- History of substance or alcohol use disorder or substance or alcohol misuse within the past 12 months that may affect study participation or outcome assessment.
- Individuals currently at high risk of suicide, severe self-harm, or experiencing an acute psychiatric crisis.
- Individuals who are currently using psychiatric medications or have undergone psychotherapy within the past 4 weeks that may significantly affect mood, motivation, or reward processing.
- Severe vision or hearing impairments that cannot be corrected and would interfere with task performance.
- Contraindications to MRI scanning, including metallic implants, pacemakers, severe claustrophobia, or other conditions incompatible with MRI.
- Pregnancy or breastfeeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motivational Interviewing-based AI chatbot group
Motivational Interviewing-based AI chatbot intervention
|
The experimental chatbot is designed to use principles of Motivational Interviewing to support participants in exploring their personal values, motivation for change, and daily behavioral goals related to pleasure, engagement, and reward-seeking.
During the intervention period, participants will interact with the chatbot regularly through brief text-based conversations.
The chatbot will provide empathic, non-judgmental responses, encourage reflection on current difficulties, and help participants identify small, feasible actions that may increase daily engagement and positive experiences.
It will not provide diagnosis, crisis counseling, or medical treatment.
|
|
Active Comparator: Active control chatbot group
Active control nature-story chatbot intervention
|
Participants will interact with a chatbot matched in format and frequency of use.
This chatbot will provide neutral nature-related stories or general natural history content.
It will be designed to maintain participant engagement while avoiding therapeutic techniques, motivational interviewing strategies, behavioral activation guidance, or personalized mental health advice.
This active control condition will help control for nonspecific effects of chatbot interaction, attention, expectancy, and digital engagement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neural Activity During Social Incentive Anticipation
Time Frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Participants will undergo task-based BOLD fMRI while completing the Social Incentive Delay Task.
Neural responses during the anticipation of social incentive cues will be compared with responses to neutral cues using a general linear model.
Pre-to-post intervention changes will be evaluated from the resulting beta contrast estimates.
|
Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
|
Neural Activity During Monetary Incentive Anticipation
Time Frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Task-based BOLD fMRI data will be acquired while participants perform the Monetary Incentive Delay Task.
Neural responses associated with the anticipation of monetary reward and punishment will be estimated using a general linear model.
Beta contrast estimates will be calculated for monetary reward versus neutral and monetary punishment versus neutral conditions.
These estimates will be used to assess changes between baseline and post-intervention.
|
Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral Responsiveness to Social Incentive Cues
Time Frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Reaction time, accuracy, and hit rate will be calculated separately for social incentive cue conditions and neutral cue conditions in the Social Incentive Delay Task before and after the intervention.
Behavioral differences between social incentive and neutral cue conditions will also be derived and compared from baseline to post-intervention.
|
Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
|
Behavioral responsiveness to monetary incentives
Time Frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
The Monetary Incentive Delay Task will be administered before and after the intervention.
Reaction time, accuracy, and hit rate will be extracted separately for monetary incentive cue conditions and neutral cue conditions, and changes in behavioral differences between monetary incentive and neutral cue conditions will be calculated.
|
Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- BAM_lab_MI_03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerRecruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on MI Chatbot Interaction
-
University of Electronic Science and Technology...Recruiting
-
University of Electronic Science and Technology...Recruiting
-
University of Electronic Science and Technology...Recruiting
-
Georgia Institute of TechnologyNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
The University of Hong KongRecruitingDrug Abuse | Adolescent BehaviorHong Kong
-
Yonsei UniversityBlueSignum CorporationRecruitingAlcohol Drinking | High-Risk Drinking PatternsSouth Korea
-
Distrito Sanitario AlmeriaJunta de AndaluciaCompletedDigital Health | Workplace Violence | Health Professionals | ChatbotSpain
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Corey LesterNational Library of Medicine (NLM)CompletedMachine Intelligence in the PharmacyUnited States
-
University of UtahHuntsman Cancer InstituteNot yet recruitingCancer | Financial ToxicityUnited States